1.
Adjuvant topical dorzolamide or timolol with intravitreal bevacizumab for diabetic macular edema: A double-blind randomized controlled trial. J Curr Biomed Rep. 2024;5(1):14-19. doi:10.61882/jcbior.5.1.279